Could common hepatitis b drugs damage kidneys? a study digs into the data
NCT ID NCT07730905
First seen Jul 28, 2026 · Last updated Jul 29, 2026 · Updated 1 time
Summary
This study examines whether long-term use of antiviral drugs for chronic hepatitis B is linked to kidney problems in patients who also have non-alcoholic fatty liver disease. Researchers will analyze medical records from 300 patients to compare kidney function among those taking different antivirals and those not on treatment. The goal is to identify high-risk factors that could help guide safer long-term care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- long-term oral nucleoside analog antiviral drugs (tenofovir alafenamide, tenofovir disoproxil fumarate, entecavir)
- What this could lead to
- If clear risk factors are identified, doctors may be able to monitor kidney function more closely or choose safer antiviral options for patients with fatty liver disease.
- What could go wrong
- This is a retrospective observational study, so it can show associations but cannot prove cause and effect. The results may not apply to all patient groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Foshan Hospital of Traditional Chinese Medicine
Foshan, Guangdong, 528000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan and blood test outsmart liver cancer?
- Can a new injection tame chronic hepatitis b?
- Double liver trouble: does having both hepatitis b and fatty liver speed up disease?
- A second punch against hepatitis b: interferon after RNA drugs may clear the virus
- Can fatty liver and hepatitis b together harm kidneys? a study digs into the data
- Can a new shot help control hepatitis d in people with hepatitis b?